Fresenius Medical Care AG & Co. KGaA (XETRA:FME) — Market Cap & Net Worth
Market Cap & Net Worth: Fresenius Medical Care AG & Co. KGaA (FME)
Fresenius Medical Care AG & Co. KGaA (XETRA:FME) has a market capitalization of $10.01 Billion (€8.56 Billion) as of June 17, 2026. Listed on the XETRA stock exchange, this Germany-based company holds position #2255 globally and #464 in its home market, demonstrating a 6.60% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Fresenius Medical Care AG & Co. KGaA's stock price €40.70 by its total outstanding shares 268564630 (268.56 Million). Review Fresenius Medical Care AG & Co. KGaA balance sheet liabilities to assess the company's total debt and financial obligations.
Fresenius Medical Care AG & Co. KGaA Market Cap History: 2015 to 2026
Fresenius Medical Care AG & Co. KGaA's market capitalization history from 2015 to 2026. Data shows change from $20.33 Billion to $12.88 Billion (-3.98% CAGR).
Index Memberships
Fresenius Medical Care AG & Co. KGaA is a constituent of 7 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
HDAX Performance
GDAXHI
|
$1.23 Trillion | 0.82% | #21 of 99 |
|
HDAX Price
GDAXHIP
|
$1.24 Trillion | 0.81% | #21 of 102 |
|
DAX Index
GDAXI
|
$1.04 Trillion | 0.96% | #19 of 40 |
|
DAX Price
GDAXIP
|
$1.04 Trillion | 0.96% | #19 of 40 |
|
STOXX Europe Large 200 EUR Price
LCXP
|
$7.18 Trillion | 0.14% | #105 of 182 |
|
STOXX Europe Large 200 Net Return
LCXR
|
$7.18 Trillion | 0.14% | #105 of 182 |
|
DAX Midcap Price
MKDX
|
$184.47 Billion | 5.43% | #2 of 50 |
Weight: Fresenius Medical Care AG & Co. KGaA's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Fresenius Medical Care AG & Co. KGaA Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Fresenius Medical Care AG & Co. KGaA's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.65x
Fresenius Medical Care AG & Co. KGaA's market cap is 0.65 times its annual revenue
Latest Price to Earnings (P/E) Ratio
13.09x
Fresenius Medical Care AG & Co. KGaA's market cap is 13.09 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $21.27 Billion | $17.03 Billion | $1.18 Billion | 1.25x | 18.00x |
| 2017 | $23.47 Billion | $17.78 Billion | $1.28 Billion | 1.32x | 18.34x |
| 2018 | $15.33 Billion | $16.55 Billion | $1.98 Billion | 0.93x | 7.73x |
| 2019 | $18.15 Billion | $17.48 Billion | $1.20 Billion | 1.04x | 15.12x |
| 2020 | $19.40 Billion | $17.86 Billion | $1.16 Billion | 1.09x | 16.66x |
| 2021 | $16.58 Billion | $17.62 Billion | $969.31 Million | 0.94x | 17.11x |
| 2022 | $9.09 Billion | $19.40 Billion | $673.40 Million | 0.47x | 13.50x |
| 2023 | $11.58 Billion | $19.45 Billion | $499.00 Million | 0.60x | 23.20x |
| 2024 | $13.87 Billion | $19.34 Billion | $537.91 Million | 0.72x | 25.78x |
| 2025 | $12.80 Billion | $19.63 Billion | $978.00 Million | 0.65x | 13.09x |
Competitor Companies of FME by Market Capitalization
Companies near Fresenius Medical Care AG & Co. KGaA in the global market cap rankings as of June 17, 2026.
Key companies related to Fresenius Medical Care AG & Co. KGaA by market ranking:
- HCA Healthcare, Inc. (NYSE:HCA): Ranked #329 globally with a market cap of $80.16 Billion USD.
- FRESENIUS SE+CO. ADR 1/4 (F:FREA): Ranked #999 globally with a market cap of $26.87 Billion USD ( €22.98 Billion EUR).
- Fresenius SE & Co. KGaA (XETRA:FRE): Ranked #1050 globally with a market cap of $25.58 Billion USD ( €21.88 Billion EUR).
- IHH Healthcare Bhd (KLSE:5225): Ranked #1344 globally with a market cap of $19.28 Billion USD ( RM76.79 Billion MYR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #329 | HCA Healthcare, Inc. | NYSE:HCA | $80.16 Billion | $389.97 |
| #999 | FRESENIUS SE+CO. ADR 1/4 | F:FREA | $26.87 Billion | €10.20 |
| #1050 | Fresenius SE & Co. KGaA | XETRA:FRE | $25.58 Billion | €38.85 |
| #1344 | IHH Healthcare Bhd | KLSE:5225 | $19.28 Billion | RM8.69 |
Fresenius Medical Care AG & Co. KGaA Historical Marketcap From 2015 to 2026
Between 2015 and today, Fresenius Medical Care AG & Co. KGaA's market cap moved from $20.33 Billion to $ 12.88 Billion, with a yearly change of -3.98%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €12.88 Billion | +0.66% |
| 2025 | €12.80 Billion | -7.70% |
| 2024 | €13.87 Billion | +19.75% |
| 2023 | €11.58 Billion | +27.41% |
| 2022 | €9.09 Billion | -45.19% |
| 2021 | €16.58 Billion | -14.52% |
| 2020 | €19.40 Billion | +6.88% |
| 2019 | €18.15 Billion | +18.40% |
| 2018 | €15.33 Billion | -34.69% |
| 2017 | €23.47 Billion | +10.35% |
| 2016 | €21.27 Billion | +4.62% |
| 2015 | €20.33 Billion | -- |
End of Day Market Cap According to Different Sources
On Jun 16th, 2026 the market cap of Fresenius Medical Care AG & Co. KGaA was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $10.01 Billion USD |
| MoneyControl | $10.01 Billion USD |
| MarketWatch | $10.01 Billion USD |
| marketcap.company | $10.01 Billion USD |
| Reuters | $10.01 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Fresenius Medical Care AG & Co. KGaA
Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, the United States, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arr… Read more